InsidersTradesSigma
Browse the complete record of transactions filed by Jooss Karin, Autre. Insider active across 2 companies, notably Fate Therapeutics INC. Cumulatively, 7 filings have been recorded. Total volume traded: €31k. The latest transaction was disclosed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Karin Jooss is a Director at Fate Therapeutics Inc and Gritstone bio, Inc. Her role is described as 'see remarks', indicating that she may have varied responsibilities within these companies. Her contribution is essential for the development and strategy of these biopharmaceutical firms.